BIOCHEMICAL AND PHARMACOLOGICAL CHARACTERIZATION OF SEROTONIN-ORTHO-CARBOXYMETHYLGLYCY1[125]IODOTYROSINAMIDE, A NEW RADIOIODINATED PROBE FOR 5-HT1B AND 5-HT1D BINDING-SITES

There is a lack of radioactive probes, particularly radioiodinated probes, for the direct labeling of serotonin-1B (5-HT1B) and serotonin-1D (5-HT1D) binding sites. Serotonin-O-carboxymethylglycyltyrosinamide (S-CM-GTNH2) was shown previously to be specific for these two subtypes; we, therefore, linked a I-125 to its tyrosine residue. Biochemical and pharmacological properties of S-CM-G[I-125]TNH2-binding sites were studied by quantitative autoradiography on rat and guinea pig brain sections. S-CM-G[I-125]TNH2 binding is saturable and reversible with a K(D) value of 1.3 nM in the rat and 6.4 nM in the guinea pig. Binding is heterogeneous, paralleling the anatomical distribution of 5-HT1B sites in the rat and of 5-HT1D sites in the guinea pig. The binding of 0.02 nM S-CM-G[I-125]TNH2 was inhibited by low concentrations of 5-HT, S-CM-GTNH2, CGS 12066 B, 5-methoxytryptamine, and tryptamine in both species. Propranolol inhibited the radioligand binding with a greater affinity in the rat than in the guinea pig. Conversely, 8-hydroxy-2-(di-n-propylamino)tetralin inhibited S-CM-G[I-125]TNH2 binding with a greater affinity in the guinea pig than in the rat. Other competitors, specific for 5-HT1C, 5-HT2, 5-HT3, and adrenergic receptors, inhibited S-CM-G[I-125]TNH2 binding in rat and guinea pig substantia nigra and in other labeled structures known to contain these receptors, but only at high concentrations. S-CM-G[I-125]TNH2 is then a useful new probe for the direct study of 5-HT1B and 5-HT1D binding sites.